Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372046 · ClinicalTrials.gov registry record · Phase 3
Implementing & Testing Assessment and Referral Technologies in Juvenile Justice
A Phase 3 study of Skill Development of Staff and Use of Standardized Assessment Tools, sponsored by George Mason University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT01372046: Completed Phase 3 study of Skill Development of Staff and Use of Standardized Assessment Tools, sponsored by George Mason University.
NCT01372046 is a Phase 3 study of Skill Development of Staff and Use of Standardized Assessment Tools that has completed, run by George Mason University. The registered enrollment target is 1,000 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01372046, a Phase 3 study of Skill Development of Staff and Use of Standardized Assessment Tools, has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Assess the impacts of implementing a juvenile assessment, referral, placement, and treatment planning (J-ARPP) protocol, and of different strategies for transferring J-ARPP technology, on service utilization of youth entering the juvenile justice system. 2. Assess the impacts of implementing J-ARPP, and of different strategies for transferring J-ARPP technology, on measures of organizational readiness and motivation, and staff attitudes about assessment and service. 3. Assess the impacts of implementing J-ARPP, and of different strategies for transferring J-ARPP technology, on measures of systems integration. 4. Assess fidelity to the J-ARPP protocol and the relationship between fidelity to the J-ARPP protocol and service utilization of youth entering the juvenile justice system.
Conditions Studied
Interventions
- BEHAVIORAL Training
- BEHAVIORAL Booster Sessions
Study Locations (1)
Maryland
- State of MD, Juvenile justice offices - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
What the finished NCT01372046 record still lists
NCT01372046 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher).
The record links to 2 conditions, with Skill Development of Staff appearing as the primary indexed condition, and to 2 interventions - of which Training is the first listed.
NCT01372046 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01372046 about?
NCT01372046 is a clinical study titled "Implementing & Testing Assessment and Referral Technologies in Juvenile Justice". 1. Assess the impacts of implementing a juvenile assessment, referral, placement, and treatment planning (J-ARPP) protocol, and of different strategies for transferring J-ARPP technology, on service utilization of youth entering the juvenile justice system. 2. Assess the impacts of implementing J-AR...
What is the current status of trial NCT01372046?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,000 participants. The study started on 2008-02. Estimated completion is 2011-05.
What conditions does trial NCT01372046 study?
This clinical trial studies the following conditions: Skill Development of Staff, Use of Standardized Assessment Tools.
What interventions are being tested in trial NCT01372046?
The interventions under investigation include: Training (BEHAVIORAL), Booster Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01372046?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01372046 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01372046's enrollment target sits among peer trials
1,000 296th of 2000 higher than 1,689 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia